T1	Outcomes 739 756	Asymptomatic days
T2	Outcomes 788 810	daily drug consumption
T3	Outcomes 878 894	flow-rate values
T4	Outcomes 932 981	residual volume and functional residual capacity.
T5	Outcomes 1072 1080	decrease
T6	Outcomes 1084 1100	clinical scores.
T7	Outcomes 1147 1167	significantly better
T8	Outcomes 1177 1190	run-in values
T9	Outcomes 1289 1316	non-trial drug consumption.
T10	Outcomes 1368 1377	flow rate
T11	Outcomes 1442 1454	RV/TLC ratio
T12	Outcomes 1478 1495	adverse reactions
